Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • luc
    Senior Member
    • Dec 2010
    • 469

    #31
    But counting applications are much better served by the HiSeq - if one does not need immediate turnaround.


    Originally posted by M4TTN View Post
    Info from Illumina:

    The MiniSeq is similar to the technology utilised with our NextSeq platform based on 2-channel SBS chemistry.

    Pricing Information

    MiniSeq System (SY-420-1001): £35,653
    MiniSeq Basic Plan (20004132): £3,350 for 1 additional year’s cover
    MiniSeq Comprehensive Plan (20004133): £4,021 for 1 additional year’s cover

    Code:
    High Output Kit 	2 x 150 (300bp)	7.5	25	FC-420-1003	1,046
    High Output Kit 	2 x 75 (150 bp)	3.75	25	FC-420-1002	652
    High Output Kit 	1 x 75 (75 bp)	1.875	25	FC-420-1001	558
    Mid  Output Kit	2 x 150 (300 bp)	2.4	8	FC-420-1004	384
    So upfront and service costs are half a MiSeq.
    Output for counting experiments is the same as MiSeq v3 chemistry (25 M reads)
    The only thing it lacks are long paired reads 2x300 bp (but those kits are failing at the moment anyway...) and with NexteraXT many of our fragments are shorter than 300 bp anyway...

    I think knowing what I know now...I'd probably buy one...specs are only going to improve.

    Comment

    • M4TTN
      Member
      • Jan 2014
      • 77

      #32
      Depends on how many reads you need...we are multiplexing 5-8 samples quite nicely on a MiSeq (counting expt). No need to go to higher depth for us (at least not at the moment).

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...